Walvax沃森生物
About Us
Our Company
Our Journey
Contact Us
Value of Vaccines
Products
Products List
Production
Distribution
R&D
R&D Platform
Pipeline
Investors
Media
Collaborations
Career
Responsibility
About Us
Our Company
Our Journey
Contact Us
Value of Vaccines
Products
Products List
Production
Distribution
R&D
R&D Platform
Pipeline
Investors
Media
Collaborations
Career
Responsibility
CN
EN
Media
Home
Media
2024
2023
2022
2021
2020
Nov 29, 2024
Walvax Strengthens Commitment to African Vaccine Manufacturing at EVMA Inaugural Event
Learn More
Nov 27, 2024
Walvax’s PCV13 Officially Exported to India
Learn More
Nov 15, 2024
Walvax Shares Vaccine Development Expertise at 11th National Vaccine Conference of Thailand
Learn More
Sep 18, 2024
Walvax Biotechnology Achieves ESG Rating Upgrade to BBB from MSCI
Learn More
Aug 30, 2024
New HPV vaccine from Zerun Bio receives WHO prequalification
Learn More
Aug 5, 2024
Walrinvax™ Pre-Qualified by WHO
Learn More
May 22, 2024
Walvax Participated in the Annual Investment Meeting (AIM) Congress 2024 in Abu Dhabi, UAE
Learn More
Media Contact
Media Team
media@walvax.com
General Inquiries
To contact form